Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC [Phase 2]
Phase 2 neoadjuvant trial of durvalumab with chemotherapy followed by surgery or chemoradiation and continued durvalumab in borderline resec…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies [Phase 1]
A Phase 1 clinical trial evaluating the safety and tolerability of AWT020 in patients with advanced malignancies is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents [Phase 2]
Phase 2 trial results for pembrolizumab plus chemotherapy in non-small cell lung cancer with targetable genetic alterations after progressio…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Liquid BiOpsy, Lung and Colon Cancer in AndaluciA
A clinical trial update about a liquid biopsy program in Andalusia for non-small cell lung cancer and colorectal cancer, currently enrolling…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety, immunogenicity, and preliminary clinical activity of the PDC*lung01 Cancer Vaccine in non-small cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study [Phase 3]
Phase 3 randomized, multicenter trial in resectable stage II-III non-small cell lung cancer evaluating SBRT followed by tislelizumab plus pl…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors [Phase 1]
Phase 1 trial evaluating safety and biomarker signals for DK210, an EGFR-targeting therapy, across multiple EGFR-positive solid tumors; curr…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER [Phase 1]
The DISCOVER Phase 1 trial evaluating RTA 408 in advanced solid tumors, including metastatic non-small cell lung cancer and relapsed/refract…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Radiation-induced Toxicity of the Heart [NA]
This clinical trial update describes a study on radiation-induced heart toxicity in cancers including non-small cell lung cancer and esophag…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer
A clinical trial update describes a study of physical activity during chemotherapy and/or immunotherapy in non-small cell lung cancer, with …
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC [Phase 2]
A Phase 2 trial evaluating chemoradiation followed by durvalumab for poor-risk and/or elderly patients with stage III non-small-cell lung ca…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating nivolumab and ipilimumab in combination with immunogenic chemotherapy for patients with advanced non-s…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study of IMM-6-415 in Ras/RAF-mutant solid tumors, including pancreatic ade…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)
This clinical trial update indicates ongoing recruitment to evaluate the effectiveness and safety of Trastuzumab deruxtecan (T-DXd) in Chine…
-
EMA approval · 2025-05-28EMA Authorised: Pemetrexed medac (pemetrexed) — medac Gesellschaft für klinische Spezialpräparate mbH
EMA authorised medac's pemetrexed medicine for use in non-small cell lung cancer and malignant mesothelioma.
-
CLINICAL_TRIALS withdrawal · 2025-05-26Clinical Trial Update: Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating cemiplimab for untreated brain metastases in patients with PD-L1 >= 50% non-small cell lung cancer has been withd…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Trial of NanoPac Intratumoral Injection in Lung Cancer [Phase 2]
A Phase 2 trial of NanoPac intratumoral injection in lung cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial comparing chemotherapy/radiotherapy versus concomitant chemotherapy followed by radiotherapy in stage IIIB non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reports termination of the NM21-1480 study in adults with advanced solid tumors, including non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity [Phase 2]
Phase 2 clinical trial update examining how intratumour heterogeneity influences antitumor response and resistance in non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Status update on ONC-392 showing safety, pharmacokinetics, and preliminary efficacy in monotherapy and in combination with anti-PD-1 across …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)
This clinical trial update discusses the role of gene molecular alterations as prognostic markers in patients with non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)
A completed special investigation collecting safety and efficacy data for VIZIMPRO (dacomitinib) in EGFR mutation-positive non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update covers Nano-SMART, a nanoparticle therapy with MR-guided SBRT being studied in centrally located lung tumors and …